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CROSS BORDER HEALTH CARE IN THE
EUROPEAN UNION: CHALLENGES AND
OPPORTUNITIES
Robert F. Rich*and Kelly R. Merrick**

I. INTRODUCTION
Spending on health care and health care services within countries
belonging to the Organization for Economic Co-operation and
Development (OECD) has risen sharply in the past decade.' Average
health expenditures, as a percentage of Gross Domestic Product
(GDP), have risen from 7.1% in 1990 to 8.8% in 2003.2 This sharp
increase in health care spending is a serious concern for individuals,
health care providers, policymakers, and governments across the
world. Nowhere is this concern more prevalent than within the
European Union, where Member States have been forced to adjust
health benefits and reevaluate system financing as a result of the rising
costs associated with extensive social protection systems.3
Some
countries in the European Union have been actively considering ideas
for health care system reform that challenge the assumptions central to

.Director of the Institute of Government and Public Affairs and Professor
of Law
and Political Science, University of Illinois at Urbana-Champaign. B.A. Oberlin
College, 1971; M.A. Univeristy of Chicago, 1973, Ph.D. University of Chicago,
1975.
. J.D. candidate, University of Illinois College of Law, 2007. B.A.
University of
Illinois at Urbana-Champaign, 2004.
1. Numbers indicate health spending on OECD countries, which include
Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France,
Germany, Greece, Hungary, Iceland, Ireland, Italy, Japan, Korea, Luxembourg,
Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Slovak Republic,
Spain, Sweden, Switzerland, Turkey, United Kingdom, and the United States.
ORG. FOR ECON. CO-OPERATION AND DEV., HEALTH AT A GLANCE: OECD
INDICATORs 2005 2 (Mar. 7, 2006), available at http://www.oecd.org/ dataoecd/ 58/
47/ 35624825.pdf (this is a copy of the Executive Summary, the entire report must
be ordered from OECD).
2. Id. at 11.
3. See e.g., Markus Wrz & Reinhard Busse, Analyzing the Impact of HealthCare System Change in the EU Member States-Germany, 14 HEALTH ECON. S133,
(2005) (discussing how Germany has been reforming its healthcare system since
1977).
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the traditional social welfare system, including even American
managed care models.
Within the European Union, access to health care services is a
widely recognized legal right anchored in EU legal traditions such as
the 2000 Charter of Fundamental Rights and supported by domestic
government systems.5 Yet these rising costs, coupled with problems of
resource allocation and timely access to treatment, are causing national
governments and citizens to seek health care services outside of their
own geographic borders. This so-called "cross-border care" raises
interesting legal and policy questions for the European Union and its
Member States. Currently, health care is not an area subject to EUwide regulation. Indeed, cross-border health care, that is the ability of
nationals from one European Union Member State to access health
services in another Member State, was previously a limited and strictly
regulated process within each nation-state. Within the last decade,
however, the growing cohesiveness of the European Union, an
increased mobility of persons across Member State borders, the
interest in and need for cross-border health care, and a rise in public
and governmental attention, have all resulted in legal claims being
brought before the European Court of Justice (ECJ) by patients who
wished to access health care outside their Member State of residence.
Recent judgments from the ECJ and administrative action taken by
both the European Union and. its Member States have led to greater
ease of cross-border access to health care services. Initially, crossborder care was typically viewed as an unnecessary burden on
domestic health systems and to be used only on an emergency basis.
More recently, however, the majority of policymakers and
governments have come to view cross-border care as a "right" or
"service" that requires cooperation through networking and resource
or information sharing. It is thought that this new area of cooperation
may alleviate many of the problems involving timely access and
treatment now experienced internally by Member State health

4.

See generally Yvonne Erdmann & Renate Wilson, Managed Care: A View

from Europe, 22 ANN. REV.

PUB. HEALTH

273 (2001) (discussing how some case

studies in Europe show a consideration of the American-style care practices).
"There is little doubt that US managed healthcare initiatives are followed with
considerable interest in Europe." Id. at 286.
5. See Charter of Fundamental Rights of the European Union, Dec. 18, 2000,
2000 O.J. (C 364) 16 ("Everyone has the right of access to preventive health care
and the right to benefit from medical treatment under the conditions established
by national laws and practices. A high level of human health protection shall be
ensured in the definition and implementation of all Union policies and activities.").
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systems; however, it does raise some critical legal issues, as will be
shown below. Moreover, these discussions of cross-border care are
closely related to on-going debates about health care reform and the
need to renegotiate the social contract.
In 1998, the European Court of Justice, through the landmark
decisions of Decker v. Caisse de Maladie des Employes Prives7 and
Kohll v. Union des Caisses de Maladie,8 established that health care
was a cross-border service subject to the oversight of European Union
treaties and regulations. Moreover, these decisions established that
domestic policies that placed restrictions on access to cross-border care
were in violation of European Community (Community) law. 9 In spite
of these decisions, Member States still retain the power to organize
their own social insurance schemes and generally determine the
conditions under which health care can be accessed; however, this new
case law, combined with institutional and legislative action, has more
fully developed and expanded health care access, making health care
not only a right of citizens within their own Member States, but also a
right that moves freely with them throughout the EU. Essentially, the
European Court of Justice has melded two previously distinct rights:
the domestic right to health care and the right to freedom of
movement within the confines of the European Economic Community.
These two rights, when applied to the health care systems of Member
States, create a conflict between the inherent legal right of Member
States under domestic law to organize their own internal social security
and social welfare systems, and the overarching legal obligations of the
Member States to the European Community under EU treaty law. It
is this tension that has made the area of cross-border care increasingly
controversial.
The development of a more extensive system for cross-border health
care raises a number of serious legal and policy-related considerations
both for member states of the European Union and for the European
Union as a whole. These policy and legal problems include: the
autonomy of domestic social insurance systems, disparities in resource
allocation and medical practices among the Member States, and
successful administration of cross-border movement, not only for those

6.

Remarks of Magda Rosenm6ller, EUR.

PARL. DEB.,

3 (Mar. 3, 2005),

available at http://www.iese.edu/ en/files/ 615042.pdf (public hearing held by the
European People's Party and the European Democrats).
7. Case C-120/95, Decker v. Caisse de Maladie des Employds Priv6s, 1998
E.C.R. 1-1831.
8. Case C-158/96, Kohll v. Union des Caisses de Maladie, 1998 E.C.R. 1-1931.
9. See Decker, 1998 E.C.R. at 1-1843, 1845; Kohll, 1998 E.C.R. 1-1946.
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seeking medical care, but also for students and migrant workers and
Larger considerations involve the fundamental
their families.
European
Union and the proper balance of power
structure of the
between the sovereignty of Member States and their European Union
treaty obligations.
This paper is organized into seven sections. First, we present
background information on the structure of Member State health care
systems. In the second section, we discuss the relevant provisions of
applicable European Community law. Third, we discuss the legal
framework and utilization of cross-border care prior to the Decker and
Kohll decisions. In the fourth and fifth sections, we present the
applicable ECJ cases, namely, the Decker, Kohll, Smitts-Peerbooms,
and Vaenbrakel decisions. Sixth, we analyze the European Union
administrative reactions to these ECJ rulings. The seventh and final
section of this paper presents conclusions about the process by which
the issue of cross-border care came before the ECJ, implications of the
ECJ decisions, projections about the future of cross-border care within
the European Union, and the relevance of the European health care
problem to the examination of access, equity, and cost-containment in
other health systems. We also analyze the implications of cross-border
care for broader health care and social welfare system reform.
Throughout, we examine the background, development, and expansion
of cross-border health care access within the European Union.
Specifically, we analyze how the melding of the external, primarily
European Union legal right to freedom of movement across Member
State borders with the internal, primarily domestic legal right to health
care creates an entirely new legal right to cross-border health care.
This new right presents complex and uniquely European legal and
policy-related questions.
II.

STRUCTURE OF MEMBER STATE HEALTH CARE SYSTEMS

Governments' development of respective health care systems varies
globally.' 0 For example, in Western Europe, health expenditures as a
share of Gross Domestic Product range from 11.6% in Switzerland to
6.5% in Poland." By comparison, the United States spends 15.3%.12

10.

See Elias Mossialos & Willy Palm, The European Court of Justice and the

Free Movement of Patients in the European Union, 56 INT'L SOC. SECURITY REV. 3,

3 (Apr.-Jun. 2003).
11. ORG. FOR ECON. CO-OPERATION AND DEV., OECD HEALTH DATA 2006:
How DOES THE UNITED STATES COMPARE 1 (2006), http://www.oecd.org/

dataoecd/ 29/ 52/ 36960035.pdf.
12. Id.
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The Member States of the European Union are characterized by
state managed health care systems, with the recognition of health care
as a "right" to be enjoyed by all. 3 The Ljubljana Charter, introduced
in 1996, explicated the fundamental principles that underlie European
social welfare and health systems.' 4 Among these principles is the
concept that "[h]ealth care reforms must be governed by principles of
human dignity, equity, solidarity, and professional ethics."' 5 Health
care is a right, with an emphasis on "universal coverage and equitable
access by all people to the necessary care."16 To attain universal
coverage, health care systems should be financed in an "efficient" and
"sustainable" manner.'7 Additionally, governments are required to
"play a crucial role in regulating the financing of health care
systems."' 8 The health care systems of the European Union Member
States are therefore characterized by high levels of public funding,
resource allocation through rationing to control costs, and continual
efforts at reform.
Traditionally, the regulation and evolution of health care within the
European Union was left to the internal political and administrative
mechanisms of the Member States. From such developments, these
national health care systems are based primarily on two distinct
systems: the Bismarckian system (compulsory social insurance) and the
Beveridgian system (national health service).' 9
The compulsory social insurance system insures the entire
population of a nation state through either a reimbursement or a
systems compensate
benefits
in kind
system.services,
Reimbursement
system, the
in
patient for
outpatient
and a third-party-payer

13. Robert Rich, Health Policy, Health Insurance and the Social Contract, 21
& POL'Y J. 397, 299 (2000) (stating that health care in the United
States is viewed as a privilege, not a fundamental right).
14. See WHO/Europe, The Ljubljana Charter on Reforming Health Care,
1996, http://www.euro.who.int/AboutWHO/Policy/20010927-5 (last visited Dec.
17, 2006).
15. Id. at art. 5.1.
16. Id. at art. 5.5.
COMP. LAB. L.

17.
18.

Id.
Id.

19.

WILLY PALM, JASON NICKLESS, HENRI LEWALLE, ALAIN COEHEUR, Ass'N

INT'L DE LA MUTUALITt, IMPLICATIONS OF RECENT JURISPRUDENCE ON THE COORDINATION OF HEALTH

CARE PROTECTION

SYSTEMS

2

(2000),

http://www.ose.be/ health/ files/ KDsyntEN.PDF [hereinafter AIM
study was carried out for the European Commission.
20. Id.

available at

REPORT].
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which the insurance carrier directly reimburses the hospital or doctor,
is employed for more costly procedures.2 ' Thus, reimbursement
systems, by not requiring the patient to use a certain provider, allow
for the greatest level of patient choice.2 2 Benefits in-kind-systems, on
the other hand, offer direct benefits through specific providers."
Patient freedom of choice is therefore limited within this system, and
specialist procedures are only performed on a referral basis.24
Member States which have a national health service system provide
universal coverage to all residents through a publicly-organized and
financed system. This tax-financed system provides all medical
services and funds the health care providers. 25 Medical services are
generally free of charge, but patients must receive their care from
providers within or connected to the public health system.26 Key
examples of Bismarckian reimbursement systems include Belgium,
France, and Luxembourg.27 Countries with Bismarckian benefits in
28
The29United Kingdom
are centralized
Austria andnational
the Netherlands.
kind
systemshave
health services.
and Ireland
A. Cost Containmentand Health Care Rationing

Due to the emphasis on universal access, national health services
must rely on rationing and prioritization of care to reduce costs. This
is often accomplished through the use of "waiting lists," in which
patients are prioritized according to the urgency of their medical
needs. Waiting lists have received media attention in recent years,
especially in Britain where the government had to defend itself against
claims of lengthy wait times and perceived insensitivity to the
problem.30 A 2001 United Kingdom National Health Service National

Audit Office Report found that patients with life-threatening illnesses
often face longer wait times so that hospitals can meet government-

Id.
22. See id.
23. Id.
24. See id.
21.

25.
26.
27.
28.
29.

AIM REPORT, supra note 19, at 3.
Id.
Id. at 2.
Id.
Id.

30. See Ministers Savaged over Waiting Lists, BBC
http://news.bbc.co.uk/ 1/ hi/ ukpolitics/ 1458049.stm.

NEWS,

July 26, 2001,
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For example, the report cited a case of routine
mandated targets.
reverse vasectomies, where patients with bladder tumors experienced
delays in care so that the procedures could be performed before an
eighteen month government target.32
In response to public criticism about long waiting lists, the United
Kingdom Department of Health recently set reform goals aimed at
reducing patient waiting times.33 In 1999, approximately 131,000
people had been waiting for nine months or more for admission to a
National Health Service (NHS) hospital, and 47,000 of this group had
been waiting more than a year.34 By March 2004, fewer than fifty
patients were waiting more than nine months for NHS hospital
Similar improvements were made in the wait times for
admission.
first outpatient appointments: in October 2002 more than 111,000
patients had waited more than four months for a first outpatient
appointments; in March 2004 eighteen patients had waited more than
four months.36
37
The Netherlands has set standards for "acceptable waiting times.,
For outpatient care, the wait time is five weeks, and for hospitalization,
the wait time is seven weeks.38 Patients can, however, select hospitals
based on their current wait lists, and this may shorten the wait time by
several weeks. 3' Life-threatening disorders, such as the need for openheart surgery and percutaneous angioplasty, entail a much shorter wait
time of one to three weeks. 40 The 2004 waiting list statistics reflect
these goals, showing waiting times of 4.2 weeks for outpatient care, 4.9

31.
AND

Id. See also U. K., DEP'T OF HEALTH, HC 221, Sess. 2001-2002, INPATIENT
NHS 1 (2001), available at
IN
THE
WAITING

OUTPATIENT

http://www.nao.org.uk/ publications/ naoreports/ 01-02/0102221es.pdf.
32. BBC NEWS, supra note 30.
33.

HEALTHCARE

COMM'N,

STATE OF HEALTHCARE

REPORT 34 (2004),

available at http:// www. healthcarecommission. org. uk/ _db/ _documents/
04006366.pdf. The Healthcare Commission is not a British government agency,
but rather an independent inspection agency set up by the government.
34.
35.
36.
37.

Id.
Id.
Id.
See

DUTCH DEP'T OF HEALTH, WELFARE AND SPORT, NEW FOUNDATIONS

FOR HEALTH CARE WITH A SOLID FUTURE: PRELIMINARY NATIONAL REPORT ON

CARE AND LONG TERM CARE 10, tbl. 3 (2005), available at
http://www.npoe.nV doc/ definitief_ landenrapport_ OMC_ gezondheidszorg.pdf.
38. Id. at 10.
HEALTH

39.
40.

Id.
Id.
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weeks for day treatment, and 5.5 weeks for clinical hospitalization.
Still, greater access to cross-border care may provide for shorter
waiting times, as patients would be able to access care in other
Member States, thereby shortening wait lists in their state of
residence.42
B. Member State Health Care Reform

The health care systems of the individual Member States have, as a
whole, experienced multiple and distinct reform cycles. 3 In 1980,
reforms focused on reducing costs in the face of low economic growth
caused by the oil crisis of 1973-1979." The most recent reforms fall
into two major categories: those of Western Europe and those of the
Western Europe goes
former Soviet bloc, now Eastern Europe.
through a reform cycle every three to five years. These reforms do not
impact health care organization or structure, but rather attempt to
resolve problems of equity and access.46 Conversely, Eastern Europe

has faced more structural challenges, focusing on funding as well as the
47
improvement and delivery of health services.
Key to current reform efforts is the stark difference in health care
outcomes experienced between the wealthier, traditionally western
Member States and the newly integrated Eastern European Member
States. The regional disparity in five-year survival rates for breast
cancer illustrates this difference, and may owe its explanation, at least
partially, to the region's differing abilities to allocate resources. 8 For

41.

Id. at tbl. 3.

42. The ECJ in Smits-Peerbooms specifically mentions the idea of patients
experiencing undue delay as a potential justification for patients to seek crossborder care. However, studies after Smits-Peerbooms indicated that patients still
prefer to stay in their Member State of residence to receive care, rather than
seeking medical care across borders. See Werner Brouwer et.al., Should I Stay or
Should I Go? Waiting Lists and Cross-BorderCare in the Netherlands, 63 HEALTH
POL'Y 289, 292, 293-94 (2003).
43. See EUR. PARL. Ass., The Reform of the Health Care Systems in Europe:
Reconciling Equity, Quality and Efficiency, Doc. No. 9903 (Sept. 11, 2003),

available

at

http://assembly.coe.int/

Documents/

WorkingDocs/

doc03/

EDOC9903.htm.
44. Id.
45. Id.
46. Id.
47. See id. (discussing what Eastern European countries needed to overcome
during this reform period and the success story of Hungary).
48. See Remarks of Nick Fahy, EUR. PARL. DEB., supra note 6, at 23.
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Swedish women, the survival rate is 81%; this rate drops to 58% in
49
Slovakia and Poland.
Malignant melanoma survival rates show a
similar pattern, with 89% survival rates in Sweden, 86% in the
Netherlands, to 62% in Estonia and 64% in Poland. 0 This disparity is
mostly due to variations in medical practice, but may also be attributed
to resource allocation." With these variations in mind, it can be said
that increased access to cross border health care may provide the
opportunity to equalize such variations. Such amelioration could occur
through resource and information sharing between Member State
health systems.
Fortunately, harmonization and unification are ultimately the goal of
ECJ jurisprudence, resulting in European-wide legislation and reform
initiatives. 52 Harmonization has occurred extensively in areas of the
European Union not explicitly relevant to the European market;
however, these areas have symbolic relevance, such as reform in higher
education systems.53 Yet, complete harmonization of Member State
health systems into a uniform system of health coverage for all
Europeans is unlikely, as the unification of national social protection
systems is not yet one of the aims of the European unification process;
instead, Member States are developing health programs with their own
country's goals in mind. 4 Limited harmonization may be necessary to
coordinate Member State health systems if utilization of cross-border
care increases.
III.

APPLICABLE

EU LAW

Cross-border health care raises several legal issues within the EU.
The largest issue is the interaction between the autonomy of Member

49.
50.

51.

Id.

Id.
See id.

52. Harmonization is the process through which the laws and regulations of
Member States are shaped to conform with the Treaty of the European
Community and the laws and regulations of other Member States. See GEORGE A.
BERMANN ET AL., CASES AND MATERIALS ON EUROPEAN UNION LAw 536-38 (2nd
ed. 2002).
53. Programs such as the European Action Scheme for the Mobility of
University Students (Erasmus), 1987 O.J. (L 166) 20, and the Lingua programme,
1989 O.J. (L 239) 24, previously utilized to encourage education in foreign
languages, were created to promote the mobility of students across Member State

borders.

See Koen Lenaerts, Education in European Community Law after

"Masstrich," 31 COMMON MKT. L. REV. 7, 19-20, 28 (1994).
54. See Mossialos & Palm supra note 10, at 3.
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State social security systems and the treaty-based structure of the
European Union." For half a century, Member States have formed a
contrsuctive community with the treaties of the EU serving as an
56
emerging constitution.
The treaties that formed the European
Community emphasize both the freedom of movement and the right to
provide (and thus receive) services in the Member States. 7 Yet, health
care and other social security systems have traditionally remained
under the exclusive jurisdiction of Member State governments. 8 It is
this balance between the sovereignty of Member States to organize
their own social security systems, the Member States' recognition of
the right to health care access, and the EU emphasis on freedom of
movement and freedom to receive services that is central to the
problem of cross-border care.
Initially arising out of the unification of the European coal and steel
industries in the 1951 Treaty of the European Coal and Steel
Community, the European Union was created by the Treaty of
Maastricht, which became effective on November 1, 1993." 9 The
treaty-based structure of the EU is basic to the legal and policy
questions raised by cross-border care.
The EU is a unique

55. The balance between Member State domestic health law and European
Union treaty obligations can not be easily harmonized. See Antonio Segura
Serrano, Improvements in Cross Border Access to Health Care in European Union,
43 HARV. INT'L. L. J. 553,561-62 (2002).
56. See BERMANN ET AL., supra note 52, at 30. See also Carlos Closa Montero,
Between EU Constitution and Individuals' Self: European Citizenship, 20 LAW &
PHIL. 345, 351-53 (2001)

The reference to the EU Treaties as a constitution relies basically on the
utilization of the formal concept of constitution: the Treaties have a
constitutional-like legal supremacy which has been solidly constructed by
the ECJ case-law through the principals of supremacy ... the doctrine of

pre-emption, and the principle of direct effect and direct applicability.
Id. at 351.
57. See Treaty Establishing the European Community, 2002 O.J. (C 325) 33,
54-55 [hereinafter EC Treaty]. See generally, D. Bruce. Shine, The European

Union's Lack of Internal Borders in the Practice of Law: A Model for the United
States, 29 SYRACUSE J. INT'L. & CoM. 207, 212-26 (2002) (providing both a review

of the European Union right to freedom of movement, establishment, and to
provide services, and how these rights have had implications upon the Member
Stats).
58. AIM REPORT, supra note 19, at 2.
59. EUR. COMM'N, The ABC of Community Law 7-8 (5th ed. 2000), availableat
http://europa.eu.int/ eur-lex/ en! about/ abc-en.pdf (prepared by Dr. Klaus-Dieter

Borchardt).
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organization in which the twenty-five Member States have ceded many
sovereign rights to the European Union. 6° The EU, through its treaty
structure, is able to enact laws and regulations that have a similar
effect to domestically enacted laws within the individual states;
community laws also supplant national laws when the two are in
conflict.6'
The EU's legal framework is comprised of a series of treaties and
subsequent regulations enacted by the European Commission and the
EU Parliament.
The 1957 Treaty of Rome 62 established "four
fundamental freedoms" which have become the basis for the freedom
of movement in the European Union. The four freedoms are 1)
freedom of movement; 2) freedom of people; 3) freedom of goods and
services; and 4) freedom of capital. 63
The right to freedom of
movement between the borders of Member States is stated in Article
18 of the European Community Treaty: "Every Citizen of the Union
has the right to move and reside freely within the territory of the
Member States, subject to the limitations and conditions set out in this
Treaty and by the measures adopted to give it effect." 64 The concept of
free movement and free access to goods and services forms the legal
basis for the Kohll and Decker decisions, as the prior regulations that
governed cross-border care were found to be a violation of these
fundamental freedoms.65
Additionally, the EC Treaty's Articles 49 and 50 apply to the free
movement of goods and services within the then European
Community. Article 49 states the principle of freedom of movement of
goods and services within the Community.
Restrictions against
providing services on the basis of Member State nationality are
prohibited:
Within the framework of the provisions set out below,
restrictions on freedom to provide services within the
Community shall be prohibited in respect of nationals of
Member States who are established in a State of the Community
other than that of the person for whom the services are intended.
The Council may, acting by a qualified majority on a proposal
from the Commission, extend the provisions of the Chapter to

60. Id. at 7.
61. See id. at 58-59, 100-02.
62. Treaty Establishing the European Economic Community, Mar. 25, 1957,
298 U.N.T.S. 11 [hereinafter EEC Treaty].
63. See id. tits. I, It.
64. EC Treaty, supra note 57, at 45.
65. See infra page 4.
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nationals of a third country who 9rovide services and who are
established within the Community.
The definition of what services fall under Article 49 is provided in
Article 50:
Services shall be considered to be 'services' within the meaning
of this Treaty where they are normally provided for
remuneration, in so far as they are not governed by the
provisions relating to freedom of movement for goods, capital
and persons. 'Services' shall in particular include: (a) activities
of an industrial character; (b) activities of a commercial
character; c) activities of craftsmen; (d) activities of the
professions.
This Article therefore defines services as all commercial, profession,
industrial, and craftsman activities, and requires that these services be
provided in a Member State under the same standards and regulations
that would be available to a national of that Member State providing
the same service. In 1984, the European Court of Justice case Luisi
and Carbone v. Ministero del Tesoro established that health care was a
"service" under EC law. 68
Cross-border health care prior to Decker and Kohll was regulated by
Article 42 of the EC Treaty. Article 42 relates to the free movement
of workers across Member State borders, and is the basis for European
Union Regulations 1408/71 and 574/42.69
Article 42 specifically
guarantees social security rights by including periods of insurance,
residence, or employment in another Member State. 70 Together,
Article 42 and EU Regulations 1408/71 and 574/42 allow for the export
of some social security benefits, forbid discrimination based on
nationality or Member State of residence, and determine what
Member State legislation should be applied to social security rights.7'
The type of coordination between Member State social security
systems described in Article 42 regulates pensions and health care
services of migrant workers and their dependents. 72 The mobility of

66. EC Treaty, supra note 57, at 54.
67. Id. at 55.
68. Case C-286/82 and C-26/83, Luisi and Carbone v. Ministero del Tesoro,
1984 E.C.R. 377,403.
69. See infra pp. 4-5.
70. EC Treaty, supra note 57, at 52.
71. See id.; Council Regulation 1408/71, art. 22 (EC), available at http://eurlex.europa.eu/ LexUriServ/ site/ en/ consleg/ 1971/R/ 01971R1408-20050505-en.pdf;
AIM REPORT, supra note 19, at 4.
72. Id.
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workers within the EU and the removal of barriers to their free
movement were essential to the development of a strong economic
system. Workers who went cross-border for their employment are
covered by two health care systems: that of their resident Member
State and their Member State of employment. This coverage is no
73
longer valid once employment ceases.
Article 22 of Regulation 1408/71, which originates from Article 42 of
the EC Treaty, describes two circumstances for a European Union
resident to receive care outside his/her Member State: temporary stay
or planned care. 4 A person temporarily staying in a Member State
who requires immediate medical attention can do so, on location, at
the expense of the state.7 5 These health services are provided under
the laws and regulations of the state in which the patient is located 6
Reimbursement is based on the established tariffs of the state where
treatment was provided 7 An Ell form must be completed prior to
care and charges must be initially paid by the patient with the ability to
be reimbursed upon return to the home Member State. 8 This delayed
reimbursement would allow the home state to reimburse according to
the price for medical services within that home state 9
Take, for example, the case of Mr. Y, a resident of Germany who is
vacationing in Italy. During his holiday, Mr. Y is injured in a car
accident. Mr. Y is entitled to immediate medical attention in Italy, and
the medical care will be given to him under the laws and regulations of
Italy. If Mr. Y fills out an Ell form (because his stay is a temporary
one), his insurer will directly reimburse the Italian medical providers.
Alternatively, if Mr. Y fails to fill out this form, he must initially pay
the medical costs in Italy at Italian rates. He can later apply for
reimbursement when he returns to Germany, where he would be
reimbursed at the German rates.
Planned care is another option for patients wishing to utilize crossborder health services. In this case, prior authorization from one's
health insurance institution, via the El12 form, must be obtained and
presented to the institution from which health care will be received.80
Member States generally have wide discretion in determining if prior

73.

Id.

74.

Id. at 4-5.
Id.
See Mossialos & Palm, suppra note 10, at 11.
See id. See also AIM REPORT, supra note 19, at 5.
See AIM REPORT, supra note 19, at 4-5.
See id.
See id. at 5.
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authorization should be granted, however, there are specific situations
under the regulations in which prior authorizations cannot be refused,
specifically:
[tihe treatment required by the interested party is part of the
health care package covered by the social protection system in
the area of health care; and [] this treatment cannot be given to
him in his State of residence within the period that is normally
necessary, in view of his current state of health and the probable
course of his disease.81
For example, if Ms. X, a resident of Spain, would like to obtain
health care in France for ovarian cancer, she may do so if her
treatment is covered by her insurer in Spain, and she would not be able
to have this care in Spain in a period that is "normally necessary."
Under this definition, insurers would have wide discretion to reject or
accept claims for cross-border care because "normally necessary" is
left to broad interpretation.
IV. CROSS BORDER CARE PRIOR TO DECKER AND KOHLL

Prior to Decker and Kohll, studies published by the European
Commission indicate that the financial impact of cross-border care
within the European Union was negligible. 82 In fact, in 1999 crossborder health care was only between 0.3% and 0.5% of total
expenditures on health care, averaging less than C2.00 per inhabitant of
the European Union.83 In the smaller Member State of Luxembourg,
the financial situation was atypical, with cross-border utilization of
health care accounting for 9% of health care spending. 84 This averages
to a more substantial E116 per inhabitant. This higher cost was most
likely due to the limited medical infrastructure in this small Member
State, which leads to a greater use of authorized health care in other
states. The highest proportion of cross-border claims was France, with
40% of all claims. 85 The tourism industry is largely responsible for
these claims, as tourists use the French health care system during their
time abroad.86

81. Id.
82. Id. at 6.
83. Id., citing J. Hermesse, The Opening of Frontiersto Patients, Symposium,
Association International de la Mutualitd, Luxembourg, (November 18, 1998) 4958.
84. AIM REPORT, supra note 19, at 6.
85. Id.
86. Id.
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Planned health care in another Member State using prior
authorization from the home country was also limited. As mentioned
earlier, E112 forms are used for such a request. In 1999, the numbers
of planned health care abroad cases that were authorized via E112
forms were 850 in Austria, 40 to 50 in Denmark, 20 in Sweden, there
were 789 authorizations and 451 refusals in France from the period of
1996 to 1999.87 Requests for prior authorization were generally refused
if the procedure was already available in the patient's state of
residence. 8
Two possible explanations for such a limited use of cross border care
exist. Either the limited use of cross-border care was due to restrictive
policies, or, in general, there is a low demand for treatment outside
one's own Member State. 9 With these explanations in mind, it is
important to note that the utilization of cross border care seems to be
limited to border areas, highly specialized services, medical procedures
for which a patient faces waiting lists in their own member state, and
medical products "for which comparisons between price and quality
are possible or which can be purchased remotely." 90
Increased accessibility to cross-border care and additional
information about what medical care is available in other countries
may encourage patients to use more cross-border care than previously.
This may be especially relevant in health care systems that rely on
waiting lists to manage health services, such as in the Netherlands and
Great Britain. 91 Another increasingly relevant issue is the growth of
specialization, in which a specialized center, doctor, or clinic actively
seeks patients both outside and within their national borders.92
CROSS-BORDER

V.

HEALTH CARE AS A RIGHT: DECKER V. CAISSE

DE MALADIE DES EMPLOYES PRIVES AND KOHLL V. UNION DES
CAISSES DE MALADIE

In the landmark cases of Decker v. Caisse de Maladies des Employes
Prives and Kohll v. Union de Caisses de Maladie, the European Court
of Justice held that prior authorization for care abroad was not a
necessary prerequisite for reimbursement in one's own Member

87. Id.
88. Id.

89.

See id. at 7.

AIM REPORT, supra note 19, at 7.
See Brouwer et. al., supra note 42, at 292.
92. See AIM REPORT, supra note 19, at 21.
90.
91.
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State. 93 Moreover, as will be shown, the process of seeking prior
authorization conflicted with the freedoms essential to the European
Community/Union. In Kohll, a Luxembourg citizen wished to obtain
reimbursement for orthodontic treatment provided in Germany
without prior authorization; 4 in Decker a Luxembourg citizen was
awarded the right to obtain reimbursement for prescription glasses
provided in Belgium without prior authorization."
The two cases of
Decker and Kohll were pivotal in that they marked a turning point in
European law. After these landmark cases, cross-border health care
was recognized not as a privilege of those who could afford to pay, but
as a universal right for all citizens of the European Union.
The European Court of Justice looked to three main sources of law
to reach its decision in Decker and Kohll: Articles 49 and 50 of the EC
Treaty; 96 existing jurisprudence that established health care as services
under these articles; 97 and Article 42, which relates to the free
movement of workers across Member State borders and is the basis for
European Union Regulation 1408/71. 9'

The question under consideration by the ECJ in Decker and Kohll
was essentially if EC Treaty Articles 49 and 50 are the dominant laws
under which Member State domestic prior authorization laws should
be analyzed:
[a]re Articles 59 and 60[ 99] of the Treaty establishing the EEC to
be interpreted as precluding rules under which reimbursement of
the cost of benefits is subject to authorization by the insured
person's social security institution if the benefits are provided in
a Member State other than the State in which that person
resides?W°
The Court was therefore deciding if the pre-authorization
requirements of Member State health care systems for care abroad

93. See Decker, 1998 E.C.R. at 1-1831; Kohll, 1998 E.C.R. at 1-1931.
94. Kohll, 1998 E.C.R. at 1-1838.
95. Decker, 1998 E.C.R. at 1-1834.
96. See id. at 1-1839. See also supra nn. 66-67 and accompanying text.
97. See e.g., id. at 1-1841 (citing Luisi and Carbon, 1984 E.C.R. 377).
98. See id. at 1-1839. See also surpa nn. 72-74 and accompanying text.
99. The revision and subsequent renumbering of the Treaty Establishing the
European Community in 2002 resulted in the fact that the Court in Decker and
Kohll refers to Articles 49 and 50 by their previous numbering, which was Articles
59 and 60, respectively. The content of the articles did not change. Such a
treatment by the Court is found in all of the decisions herein.
100. Decker, 1998 E.C.R. at 1-1839.
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were subject to the freedom of movement provisions of Articles 49 and
50.
In its decision in both Decker and Kohll, the European Court of
Justice stressed that Member States have the power to regulate and
organize their own social security systems.'01 Yet, the Court continued,
the freedom to organize one's own social security system cannot "give
rise to discrimination between nationals of the host state and nationals
of the other Member States."' ' These social security provisions are
not exempt from the oversight of European Law, and therefore are
subject to the basic EC Treaty principles of free movement.'0 3 The
Court concluded that although Member States have the authority to
organize their respective social insurance systems, these systems
impact free movement within the community, and are thus subject to
the freedom of movement principles of the EC. °4
In fact, the requirement of prior authorization, by discouraging
patients from seeking care outside of their Member State, constitutes a
barrier to the free movements of patients. 0 5 Such a barrier cannot be
legitimately justified on the basis of either public health or the
financial stability of the Member States' internal social welfare
system. 1 6 In terms of reimbursement, the Court specifically held in
Kohll that Article 22 of Regulation 1408/71, which requires prior
authorization for coverage of care provided in another Member State
and provides for reimbursement according to the tariffs in the state
where care was provided, does not prevent reimbursement at the tariff
of the home state in the absence of prior authorization. 0 7
The Court in Decker and Kohll, therefore, found that there were no
sufficient reasons to justify the restrictions placed upon cross-border
health care in the prior authorization system.
[While] Community law does not detract from the power of the
Member States to organize their social security systems .. .
[they] must nevertheless comply with Community law when
exercising those powers ... [T]he fact that national rules ... fall
within the sphere of social security cannot exclude the

101. Decker, 1998 E.C.R. at 1-1843, 1845; Kohl, 1998 E.C.R. at 1-1942-43. See
also Mossialos & Palm, supra note 10, at 8.
102. Decker, 1998 E.C.R. at 1-1843 (internal quotations omitted).
103. Decker, 1998 E.C.R. at 1-1843; Kohll, 1998 E.C.R. at 1-1943.
104. Decker, 1998 E.C.R. at 1-1843; Kohl, 1998 E.C.R. at 1-1943.
105. Decker, 1998 E.C.R. at 1-1857; Kohl, 1998 E.C.R. at 1-1946.
106. See Decker, 1998 E.C.R. at 1-1855-56; Kohl, 1998 E.C.R. at 1-1947-48,
1949, 1950.
107. See Kohl, 1998 E.C.R. at 1-1943-44.
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application of Articles 59 and 60 of the Treaty ... [T]he fact that

a national measure may be consistent with a provision of
secondary legislation, in this case Article 22 of Regulation No
1408/71, does not have the effect of removing that measure from
the scope of the provisions of the Treaty.""
Finally, the Court recognized that its ruling would have ramifications
concerning Member State policy. The Court therefore encouraged the
EU to harmonize its efforts on cross-border health care:
Action by the Community legislature aimed at harmonizing the
area in question so as to allow genuine and effective freedom of
movement for patients, which would be a significant factor in the
creation of a single integrated market, would be welcome . . .
[T]he Community legislature should at least act, and do so
promptly, to broaden the range of circumstances in which
authorisation may not be refused. There is no doubt that it
would be advantageous in many respects for authorisation to be
granted in all cases in which the insured person could receive
more effective treatment in another Member State .... 109
VI. CHANGES IN EUROPEAN JURISPRUDENCE AFTER DECKER AND
KOHLL: THE GERAETS-SMITS/PEERBOOMS, ABDON VANBRAEKEL
A. O, AND WATTS DECISIONS

Decker and Kohil left several major questions unresolved that were
addressed by later ECJ jurisprudence. The two key issues were: (a) do
the rulings in Decker and Kohll apply to both benefits-in-kind and
reimbursement health care systems within the European Union and
(b) do the rulings apply to both outpatient services (that do not require
pre-authorization) and hospitalization services (that do require preauthorization). Moreover, it was unclear if health services should be
reimbursed at the tariff of the home Member State or the state in
which the health care service was provided. 110 In 2001, the ECJ
combined the next two cases, Geraets-Smits v. Stichting Ziekenfonds
and Peerbooms v. Stichting CZ Groep Zorgverzekeringen. 1 ' The ECJ
holdings in these cases resolved the questions left from Decker and
Kohll.
In the case of Garets-Smits, Smits received treatment for Parkinson's
disease from a specialized clinic in Germany. Prior authorization was
108.
109.

Kohll, 1998 E.C.R. at 1-1943-44.
Decker, 1998 E.C.R. at 1-1869.

110. See AIM REPORT, supra note 19, at 17.
111. Case C-157/99, B.S.M. Geraets-Smits v. Stichting Ziekenfonds VGZ, 20017 E.C.R. 1-5473.
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not obtained; Smits paid the clinic directly and subsequently applied
for reimbursement through the Netherlands sickness fund."'
Mr.
Peerbooms received neurological treatment in Austria; this treatment
was also available in the Netherlands on a restrictive, experimental
basis."'
In this case, prior authorization was also not obtained;
Peerbooms paid directly and later applied for reimbursements through
the Netherlands sickness fund." 4 The sickness funds rejected both
claims, and lower courts supported this decision because such services
were available in the Netherlands, and neither patient had followed
the pre-authorization requirement."5
The question before the ECJ was twofold: did Decker and Kohll
apply to benefits-in-kind systems (like that involved here with the
Netherlands) and not just reimbursement systems; and did Decker and
Kohll apply to both outpatient and hospitalization services?" 6 GeraetsSmits held that the requirement to obtain prior authorization, as
required by the Dutch health system, was a barrier on the freedom to
provide services under Articles 49 and 50."' Thusly, the principles of
Decker and Kohll are applicable to both reimbursement and benefits8
in-kind health systems and both hospital and outpatient services."
The Court first restated the fundamental principle that all Member
States may organize their internal social security systems as they see
fit. The Court held that Community law does not detract from the
powers of the Member States to organize their social security systems,
and that, in the absence of harmonization at Community level, it is "for
the legislation of each Member State to determine, first, the conditions
governing the right or duty to be insured with a social security scheme
and, second, the conditions for entitlement to benefits."'' 9 Yet, this
allowance is coupled with the EU principle of freedom to provide
services, which can only be restricted for three reasons:
(1) ... by overriding reasons relating to the general interest and
are applied to all persons of undertakings pursuing those
activities in the territory of the State in question, in so far as that
interest is not safeguarded by the provisions to which the
Community national is subject in the Member State where he is

112. See id. at 1-5479.
113. See id. at 1-5480.
114. Id.
115. See id. at 1-5479, 5480.
116. See Geraets-Smits, 2001-7 E.C.R. at 1-5486.
117. See id. at 1-5530-33.
118.

See id. at 1-5529-30.

119. Id. at 1-5526 (citations omitted).
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established; (2) are necessary to ensure that the objective they
pursue is attained; and
(3) do not go beyond what is necessary to
12
attain that objective. 1
Here, the Court is highlighting the fundamental conflict between
Member State autonomy in the realm of domestic social services, and
the European Union right of freedom to provide services, which can
only be restricted in limited cases.
The Court did agree, however, that some restrictions on hospital
access may be necessary, as the infrastructure, geographical location
and planning were local public health issues best handled by individual
Member States:
[B]oth the objective of providing a balanced medical and
hospital service open to everyone and the objective of
maintaining essential treatment facilities and medical services on
national territory, apart from being intrinsically linked to the
method of financing the system, can be brought within the ambit
of the public health grounds which.., are capable of justifying a
restriction
on freedom to provide services, as the court held in..
121
K ohll.

The court went further, stating that an influx of cross-border patients
would jeopardize the fundamental infrastructure of Member State
hospitals:
[If insured persons were at liberty, regardless of the
circumstances, to use the services of hospitals with which their
sickness insurance fund had no contractual arrangements,
whether they were situated in the Netherlands or in another
Member State, all the planning which goes into the contractual
system in an effort to guarantee a rationalized, stable, balanced
and accessible
122 supply of hospital services would be jeopardized
at a stroke.
Therefore, the court recognized the legitimacy of restrictions on
cross-border care when such restrictions protect the organization of
hospital systems. The extent of these restrictions and how they may be
balanced with the freedom of movement and the freedom to provide
services seems yet to be fully clarified.
Another significant case is Vanbraekel v. ANMC. 123 In Vanbraekel, a
Belgian patient, Jeanne Descamps, applied to her sickness fund for

120. Id. at 1-5501-02.
121. Id. at 1-5505.
122. Id. at 1-5535.
123. Case C-368/98, Abdon Vanbraekel and Others v. Alliance Nationale des
Mutualit6s Chr6tiennes, 2001-7 E.C.R. 1-5363.
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orthopedic surgery in France. 24 Upon seeking reimbursement, the
sickness fund denied her prior authorization request and she went
ahead with treatment in France without approval from the
government. 11 A lower court dismissed her action, as a Belgian
professor found that Ms. Descamps' requested procedure could be
performed no better in France than in her home state. 26 An appellate
court reversed this decision using its own expert who determined that
Ms. Descamps required treatment abroad; she
2 7 was therefore entitled
to reimbursement for her treatment in France.
The issue before the ECJ in this case is how should Ms. Descamps'
heirs be reimbursed for her medical costs under Regulation 1408/71.2
The court held that Community Regulation 1408/71 and Article 22
guarantee the duly authorized insured person reimbursement of her
treatment costs in accordance with the legislation of the State in which
the treatment was received. 29 The court also held, on the basis of the
principle of freedom to provide services, that the insured person is
entitled to additional reimbursement from their home Member State if
their home state has a higher level of reimbursement:
Article 59 of the EC Treaty is to be interpreted as meaning that,
if the reimbursement of costs incurred on hospital services
provided in a Member State of stay, calculated under the rules in
force in that State, is less than the amount which application of
the legislation in force in the Member State of registration would
afford to a person receiving hospital treatment in that State,
additional reimbursement covering that difference must be
130
granted to the insured person by the competent institution.
In cases like this one, Ms. Descamps would be entitled to additional
reimbursement from her home Member State (Belgium) if her home
Member State had a higher level of reimbursement than the Member
State where her medical procedure was performed (France).
Hypothetically, if Ms. Z, a resident of the United Kingdom, travels to
Spain for medically necessary surgery, she would be entitled to
reimbursement at the UK rates of reimbursement, even if the cost of
her surgery in Spain was lower than the UK rates of reimbursement.
Vanbraekel therefore expands upon the rights given to patients in

124.

Id. at 1-5391.

125.

Id.

126.

Id. at 1-5391-92.

127.

Id. at 1-5392.

128.
129.

See id. at 1-5393.
Vanbraekel, 2001-7 E.C.R. at 1-5397.

130.

Id. at 1-5403.

2006]

Cross Border Health Care in the EU

Decker and Kohll, granting a higher level of reimbursement to patients
if their home Member State has a higher level of reimbursement than
the level of reimbursement available in the Member State where they
receive medical treatment.
The most recent jurisprudence relevant to patient mobility is Watts
v. Bedford Primary Care Trust, decided by the ECJ in the spring of
2006. 31' In the Watts case, Mrs. Watts, a British citizen, applied for
E112 preauthorization for treatment abroad from her local health
provider, Bedford Primary Care Trust.
Mrs. Watts wished to travel
to France for hip replacement surgery to avoid a waiting period in her
Member State of residence, Great Britain. 3 She was examined by a
government consultant, and her E112 request was denied. 34 The
reason for the denial was that Mrs. Watts would be able to have her
hip surgery in Britain within one year's time, which was not considered
an undue delay under the target waiting times for Britain's National
Health Service.'35 Yet, as Mrs. Watts' health deteriorated further, she
was reexamined by the government and moved up to a three to four
month waiting period for her surgery."' Repeated requests for E112
authorization were denied, so Mrs. Watts traveled to France for the
surgery, and then sought reimbursement. 3 7 A question referred to the
ECJ from the appeals court was if Mrs. Watts' case falls under
Regulation 1408/71 and Article 49 of the EC, thus imposing an
obligation on the British health system to reimburse her. 38
The ECJ concluded that Mrs. Watts' case did fall under the freedom
to provide services, and that an institution may not deny an E112
request for treatment abroad merely because the patient would receive
treatment in their Member State of residence within governmentmandated waiting list target periods. 39 Such determinations must be

131.

Case C-372/04 The Queen, on the application of Yvonne Watts v. Bedford

Primary Care Trust and Secretary of State for Health, (European Court of Justice
May 16, 2006), http://curia.europa.eu/ jurisp/ cgi-bin/ form.pl?lang= EN&Submit=
rechercher&numaff-C-372/04, (opinion on the second link).

132. Id. at para. 24.
133. See id. at paras. 28, 31. See also NHS Told to Fund Treatment Abroad,
BBC NEWS, May 16, 2006, http://news.bbc.co.uk/ 2/hi/ health/ 4985190.stm.
134.

Watts, supra note 131, at para. 25.

135.
136.
137.
138.

Id.
See id. at paras. 29-30.
Id. at paras. 30-31.
Id. at para. 42.
Id. at para. 2 (Court ruling).

139.
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made, to some extent, on an individual basis, and based upon an
individual's specific medical needs:
A refusal to grant prior authorisation cannot be based merely on
the existence of waiting lists intended to enable the supply of
hospital care to be planned and managed on the basis of
predetermined general clinical priorities, without carrying out an
objective medical assessment of the patient's medical condition,
the history and probable course of his illness, the degree of pain
he is in and/or the nature of his disability at the time when the
request for authorisation was made or renewed.40
Regarding reimbursement, the Court determined that a patient is
entitled to receive full reimbursements for the cost of the medical
procedure received in another Member State even if the procedure
was available free of cost in their home Member State. Specifically, if
the cost of the medical procedure is higher in the Member State where
care is received, the patient is entitled to reimbursement of the
difference between the costs; the Court continued:
[Wjhere the legislation of the competent Member State provides
that hospital treatment provided under the national health
service is to be free of charge ... the competent institution must
reimburse that patient the difference (if any) between the cost,
objectively quantified, of equivalent treatment in a hospital
covered by the service in question up to the total amount
invoiced for the treatment providing the host Member State and
the amount which the institution of the latter Member State is
required to reimburse under Article 22(1)(c)(i) of Regulation
No 1408/71 ...on behalf of the competent
institution pursuant
141
to the legislation of that Member State.
The Court summarized its holdings as follows:
The obligation of the competent institution under both Article
22 of Regulation No 1408/71 ...and Article 49 EC to authorize
a patient registered with a national health service to obtain, at
that institution's expense, hospital treatment in another Member
State where the waiting time exceeds an acceptable period
having regard to an objective medical assessment of the
condition and clinical requirements of142 the patient concerned
does not contravene Article 152(5) EC.

140.
141.
142.

Watts, supra note 131, at para. 2 (Court ruling).
Id.at para. 3 (Court ruling).
Id. at para. 4 (Court ruling). The EC Treaty, Article 152(5) reads:

"Community

action

in the field

of public health

shall fully respect the
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The Watts case, much like Geraets-Smits and Vanbraekel, addressed
a specific concern about the practical application of the rights granted
in Decker and Kohll. Watts can also be seen as a legal consequence of
the Decker and Kohll decisions, and an indication that the European
Court of Justice will continue to reinforce and expand the legal rights
guaranteed under Decker and Kohll. The right of citizens of the
European Union to access health care services in another Member
State, and be appropriately reimbursed for those services, is no longer
a theoretical right, but rather a concrete right, reinforced by an everincreasing ECJ jurisprudence on the issue. Also reinforcing this right
to cross-border care is the development of Member State and
European Union law and policy on the issue.
VII. EUROPEAN UNION RESPONSE: COMMUNICATION AND
COORDINATION BETWEEN MEMBER STATE HEALTH CARE SYSTEMS
AFTER GERAETS-SMITS AND VANBRAEKEL.

The impact of the Geraets-Smits and Vanbraekel decisions is quite
broad. Now, all Member State health systems are obligated to operate
under the rules set out in Decker and Kohll. Combined with Decker
and Kohll, Geraets-Smits and Vanbraekel strengthened the concept of
health care as a fundamental right, not only within the EU, but also
within the Member States themselves. Rather than seeing this as a
challenge to their autonomy, as Member States had reacted to the
Decker and Kohll decisions, more Member States now see health care3
services as a broader issue with more opportunity for cooperation.
Some of this optimism may be linked to the successful growth of the
European Union, and how Member States now look to European wide
solutions as an opportunity for collective problem solving. This
sentiment will most likely strengthen as the European Union continues
to become more cohesive and harmonized.
Perhaps the best statement of this transition or change of position by
the Member States was made by Robert Madelin, Director General of
14

responsibilities of the Member States for the organisation and delivery of health
services and medical care." EC Treaty, supra note 57, at 101.
143. See AIM Report, supra note 19, at 11.
Some people, however, refer to the dynamism and the positive effects that
could result from the jurisprudence as hitherto excessively strict national
barriers are lifted. By seeking to promote the public interest in the area of
health, cross-border co-operation, along with complementarity in the
supply of health care, could improve the efficiency of health care systems
and broaden the scope of treatment covered.
Id. at 11.
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Health and Consumer Protection for the European Commission,
during hearings before the European Commission on cross-border
patient mobility:
[T]he intuition that patient mobility was a key issue because
of... the threat of the legal environment has turned, I think,
into a perception that this is a thread around which you can
weave very much positive outcomes. I think that the balance
between fear and hope has changed in the last years and that
we can now see a willingness to work on this issue as one
where we're not trying to defend past practices against the
evolution of EU law; we're trying to drive forward an issue
that can ...produce better outcomes for the citizens... '44
From Madelin's perspective, cross border health care, through
resource and information sharing can be an opportunity to improve
health care outcomes for all citizens of the European Union.
The ECJ decisions galvanized the European Community to create a
variety of programs, hold legislative hearings, and engage public
interest groups in the data gathering process. 45 With the exception of
the reform of Regulation 1408/71 and the enactment of the European
Health Card to replace the Ell1 form, the Member State policy and
programmatic "reactions" are still in the developing stages. Member
States are pooling data and developing information gathering
techniques to track how and why their citizens choose to use crossborder care.146 Ultimately, this information should help to provide care
in the most equitable and cost-effective manner consistent with the
recent court decisions. As will be discussed, many controversial issues,
such as the mobility of health care professionals, and the inequity that
exists between poorer and richer Member States still need resolution
through the political process of the European Union. The major
actions taken by the EU include the High Level Process of Reflection
on Patient Mobility and Healthcare, developments of new European
Union programs, reform of Regulation 1408/71, the release of the
European Union Health Insurance card, the development of the
European Charter of Patient's Rights and 4closer examination and
analysis of current cross border coordination. 1

144. Remarks of Robert Madelin, EUR. PARL. DEB., supra note 6, at 7.
145. See infra Parts VII.A-G.
146. See infra Part VII.G.
147.

See infra Parts VII.A-G
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A. High Level Processof Reflection on Patient Mobility and Healthcare
Developments in the European Union

In 2004, following the Court decisions, ministers of health from
Austria, Belgium, Denmark, Finland, France, Germany, Greece,
Ireland, Italy, the Netherlands, Portugal, Spain, Sweden, and the
United Kingdom took part in a high level reflection process in
Brussels. The reflection process was designed to examine the current
state of cross-border health care and the directions for future reforms
that might be required in Europe after the EJC decisions.149 The
Ministers saw the ECJ decisions as an opportunity to improve health
care for all Europeans. Within this context, the "reflection process"
focused on five key themes: "[1] European cooperation to enable
better use of resources; [2] information requirements for patients,
professionals and policy-makers; [3] access to and quality of health
care; [4] reconciling national health policy with European obligations
and [5] health related issues and EU funding."' 5 °
In the end, this reflection process generated a formal report which
contained concrete recommendations to the European Commission on
patient mobility and access to cross-border care. 5' The report details
the legal consequences of the series of ECJ decisions, and how they
impact access to cross-border care and reimbursement schemes.
According to the report, non-hospital care that an individual would
receive in their Member State can be accessed in any Member State
without prior authorization and reimbursement provided at the level
of the patient's home Member State.
Previously authorized
hospitalized care may be accessed in any Member State with
reimbursement levels of the patient's home Member State.'
If a
patient plans on accessing cross-border heath services, health officials

148. EUR. COMM'N, Health & Consumer Protection Directorate-General, High
Level Process of Reflection on Patient Mobility and Healthcare Developments in the
European Union, 3, Doc. HLPR/2003/16 (Sept. 12, 2003), available at http://
europa.eu.int/ comm/ health/ phoverview/ Documents/ key01_mobility-en.pdf.
149. See id. at 2-3.
150. Id. at 4.
151.

See COMM'N OF THE EUR. COMTY., Follow-up to the High Level Reflection

Process on Patient Mobility and Healthcare Developments in the European Union,
3, COM(2004) 301 final (Apr. 20, 2004), available at http://europa.eu/ eur-lex/
en/com/ cnc/2004/ com2004_0301en01.pdf [hereinafter COMM'N OF THE EUROPEAN
CoMTY., Follow-up].
152. Id. at 2.
153. Id. at 2-3.
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in the patient's home Member State will provide information
on
14
relevant reimbursement levels and authorization requirements.
A key issue raised by the high level group was how to address the
inequities in health systems between Member States."' Many of the
new EU Member States have populations that experience lower
overall health quality, in addition to having limited access to health
Compounding this problem is the fact that many of
care resources.
these Member States under-invest in their health care infrastructure as
compared with other countries in the EU. 57 Generally, these acceding
countries invest only 4.5% of their GDP on health care compared to
8.5% of the current EU5 This dilemma is quite important because
the removal of these inequities may lead to a higher demand for crossborder care.
Overall, the European Commission has expressed interest in
developing a shared European view of health systems, and continued
investment in health and health infrastructure.1 5 9 In addition, in April
of 2004, the Commission established the High Level Group on Health
Services and Medical Care. The Group was established in response

154. Id. at 3.
155. See id. at 16-18.
156. See id. at 17.
157. COMM'N OF THE EUROPEAN COMTY., Follow-up, supra note 151, at 17.
158. Id.
159. See European Union, Health-EU The Public Health Portal of the
health-eu/
European Union, Policies, available at http://ec.europa.eu/
health in the eu/ policies/ indexen.htm (last visited Dec. 16, 2006).
The EU health strategy focuses mainly on strengthening cooperation and
coordination, supporting the exchange of evidence-based information and
knowledge, and assisting with national decision-making. To this end, the
EU is developing a comprehensive health information system to provide
EU-wide access to reliable and up-to-date information on key healthrelated topics, and hence a basis for a common analysis of the factors
affecting public health.

Id.
160. See European Comm'n, High Level Group on Care, available at
http://ec.europa.eu/ health/ ph-overview/ cooperation/ mobility/ high- levelhsmc_ en.htm (last visited Dec. 16, 2006).
The 2003 report of the patient mobility reflection process represented a
political milestone by recognizing the potential value of European
cooperation in helping Member States to achieve their health objectives.
The Commission set out its response to the report of the reflection
process in Communication COM (2004) 301 of 20 April 2004. The
primary mechanism for taking forward the work set out in the
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to a need to have a mechanism to coordinate health services and
medical care. 6' The role of the Group is to support European
"cooperation between the Member States on health services and
medical care, in order to help patients to have the high-quality health
care they seek and to help health systems to improve their
effectiveness and efficiency.", 16' The Group is comprised of senior
representatives from each Member State, additional stakeholders,
including regional and local authorities, and health care experts. The
stated goals of the Group include:
to promote cooperation between the Member States and take
forward the recommendations of the reflection process through
activities such as developing a better understanding of the rights
and duties of patients, sharing spare capacity between systems
and cooperating on cross border care, identifying and
networking European centres of reference, and coordinating
assessment of new health technologies9
The high level reflection process, its report, and the subsequent
recommendations and programs of the European Commission can best
be summarized in statements by three officials involved in this decision
making process. 6 David Byrne, the European Commissioner for
Heath and Consumer Protection stated:
EU law gives patients the right to go for treatment in other
Member States. But exercising that right can prove difficult. A
central aim of our proposal is to explain patients' rights more
clearly and ensure that they have the information they need to

Communication was to establish a High Level Group on health services
and medical care. This High Level Group started work in July 2004. It

brings together experts from all the Member States and it works in seven
main areas ....

Id.
161. See COMM'N OF THE EUROPEAN COMTY., Follow-up, supra note 151, at 1516.
162. Idat 16.
163. Id.
164. Id.
165. See Press Release, Eur. Comm'n, Healthcare cooperation, Patients to
benefit from new Comm'n proposals (Apr. 21, 2004), available at
http://europa.eu.int/ rapid/ pressReleases Action. do?reference=IP/ 04/508&format
=HTML&aged=0& language= EN&guiLanguage=en (click on "EN" under the
"PDF row).
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make use of those rights. My final goal is to achieve a European
Charter of patients' rights to which everyone can refer.' 66
Byrne characterizes cross-border care as an opportunity to relieve
strain on Member State domestic health systems, as those on waiting
lists can use underutilized health resources in another Member

States. 167
Stavros Dimas, European Commissioner for Employment and Social
Affairs, states that the goal of increased European coordination on
health care systems is to ultimately benefit the domestic health systems
of Member States:
Health systems play a vital role in combating the risk of
disease and poverty and ensuring social cohesion and
employment. Bold reforms of funding and provision are vital
to cope with demographic pressures, technological change
and rising costs and to ensure continued quality, access and
financial sustainability. Our aim is to support Member States
in ensuring quality care provision for all Europe's citizens.'
Dimas thus states the position that the role of the European Union is
to provide support for domestic Member State health systems,
emphasizing the balance that must be struck between the sovereignty
of Member State health care systems and the requirements of EU law.
This concept, as has been shown, was highlighted by the ECJ.
B. Development of New European Union Programs
In 2002 the European Union established the Community Action
Program for Public Health for 2003-2008. Cross-border collaboration
is a key component of the new program, which is centered on three key
objectives: "health information, rapid reaction to health threats and
health promotion through addressing health determinants." 6 9
Through information sharing and coordination between Member
States, the program aims to improve public health infrastructure and
outcomes. 7 ° Public health has long been a concern of the European
Union generally,17' but the increased ability of patients to access care

166. Id. at 1.
167. See id.
168. Id.
169. EUROPA - Public Health - Programme 2003-2008, http://ec.europa.eu/
health/ ph-programme/ programme-en.htm (last visited Jan. 5, 2007).
170.

See id.

171. See EC Treaty, supra note 57, at 100-01. The European Union is able to
oversee public health issues under Article 152. The Programme of Community
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across borders will likely lead to a greater need for information sharing
and cooperation. The emphasis placed on close cooperation by the
Community Action Programme for Public Health for 2003-2008 may
well be influenced by this change.
In addition, the EU's Programme of Community Action in the Field
of Health and Consumer Protection, adopted by the European
Commission on April 6, 2005, aims to provide for multinational-level
cooperation on common challenges facing Member State health care
systems. 7 2 Such common challenges include the mobility of patients
and professionals, ageing populations, and advances in medical
science.' The program will gather data and present various reports
from 2007-2013.114 The program aims to facilitate "cross-border health
care provision[s], information exchange, [promotion of] patient safety,
support to set up an EU system for centres of reference and [the]
providing [of] information on health services."' The program aims to
improve Member State health care systems and additionally "achieve
synergies between national health systems.', 7 6 Mechanisms used by
the program include the establishment of "community systems for
cooperation on centres of reference," and "information gathering and
177
exchange to enable sharing of capacity and use of cross-border care.
C.Reform of Regulation 1408/71
Since the aforementioned ECJ courses were handed down,
regulation 1408/71, which provides forms E112 and El11,' 78 and the
legal structure for cross-border health care, underwent legislative
revision to bring these regulations into conformity with current ECJ

action in the field of public health falls under this article as an "incentive measure
designed to protect and improve human health..." Id. at 101.
172. See EurActiv, EU health strategy I European Union Health & Pharma,
http://www.euractiv.com/ en/ health/ eu-health-strategy/ article-143281 (last visited
Jan. 3, 2007). See also COMM'N OF THE EUR. CoMTY., European Parliament &
Council et. al., Healthier, Safer, More Confident Citizens: a Health and Consumer
Protection Strategy, 2, 5, 8, COM(2005) 115 final, available at http://europa.eu.int/
eur-lex/ lex/ LexUriServ/ site/ en/ com/ 2005/ com2005_0115en01.pdf [hereinafter
COMM'N OF THE EUR. CoMTY., Healthier,Safer, More Confident Citizens].
173. COMM'N OF THE EUR. COMTY., Healthier, Safer, More Confident Citizens,
supra note 172, at 8.
174. See e.g., id. at 1, 9, 14, 24, 27, 33.
175. Id. at 8.
176. Id. at 31.
177.

Id.

178.

See infra Part III (pointing to the previous discussion of these forms).
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On April 29, 2004, the European Council
jurisprudence.17 9
recommended numerous clarifications to Regulation 1408/71.'80 The
E112 and Ell1 forms of this Regulation have now been replaced by
single, personalized European Health Insurance Card."'
Moreover, after this clarification, Regulation 1408/71 was extended
to cover "all nationals of Member States who are covered by the social
security legislation of a Member State."'8 2 The Council also made it
clear that coverage under the Regulation was to cover "employees,
self-employed, civil servants, students and pensioners. '' 183 The scope of
the Regulation was enlarged to cover "statutory pre-retirement
schemes."' 84 An emphasis is also placed on cooperation and mutual
assistance between the institutions of the Member States for the
benefit of citizens. 185 These changes to Regulation 1408/71 were
initially tabled in January of 2006, but changes were later enacted by
the Council on March 10, 2006.186
D. European Union Health Insurance Card

As just mentioned, a further development of Regulation 1408/71 is
the introduction of the European Union Health Insurance Card. The
card is a powerful symbol of both the extent to which patient mobility
is embraced as a right and how the formerly bureaucratic process has
been streamlined. The European Union Health Insurance Card is
used instead of the paper forms, allowing the card-holder to receive

179. See Eur. Parl., European ParliamentFact Sheet: 4.8.4 Social Security Cover
in
Other Member States of the Union, http://www.europarl.eu.int/
facts/4_8_4_en.htm (last visited Dec. 17, 2006) [hereinafter EUR. PARL., European
ParliamentFact Sheet].
180. See id.
181. Eur. Public Health Alliance, European Health Card Launched on 1 June
2004, June 30, 2004, http://www.epha.org/ a/1333 [hereinafter Eur. Public Health
Alliance, Eur. Health Card Launched].
182. EUR. PARL., European ParliamentFact Sheet, supra note 179.
183.

Id.

184.

Id.

185. Id.
186. Press Release, Council Eur. Union, 2714th Council Meeting Employment,
Social Policy, Health and Consumer Affairs 20-21 (Mar. 10, 2006), available at
http://europa.eu/ rapid/ pressReleasesAction. do?reference=PRES/ 06/55&
format= HTML&aged=l& language=EN& guiLanguage=en (click on "EN" under
the "PDF" option).
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medical attention while temporarily in another Member State.'87
Anyone who is insured by a social security system of a Member State is
eligible to receive a European Union Health Insurance Card.' In its
first phase, the card only replaced the Ell form, which is used for
temporary stays such as vacations in another Member State. 89 In the
second phase, the card will substitute all remaining paper forms
relating to temporary stays.' 9 These paper forms include those for
employees relocated to another country (E128), job seekers (E119),
and students (E128).' 9' This card can only be used for "medically
necessary care" occurring during a temporary stay in another member
sate, and does not relate to the planned care or pre-authorization
issues concerning form E11229
The European Union Health Insurance Card was introduced in all
EU Member States starting on June 1, 2004 and is currently used all
EU Member States. In addition, Switzerland, Iceland, Norway, and
Lichtenstein currently use the card in place of the Ell forms. 93 The
eventual goal is that the card will be issued with an electronic chip that
will be part of a larger "e-Health" initiative, containing patient records
and previous medical history and providing for greater information
sharing across borders. 94 Such advances will only lead to the removal

of additional barriers to cross-border care.195

187. Press Release, Eur. Comm'n, Eur. Health Insurance Card: Frequently
Asked Questions 1 (Mar. 26, 2004), available at http:// europa.eu.int/ rapid/
pressReleasesAction.do? reference= MEMO/ 04/75& format= HTML& aged=
0&language= EN& guiLanguage=en (click on "EN" under the "PDF" option)
[hereinafter Press Release, Eur. Union, Eur. Health Insurance Card].
188. Id. at 2.
189. Eur. Public Health Alliance, Eur. Health Card Launched, supra note 181.
See also Press Release, Eur. Union, Eur. Health Insurance Card, supra note 187, at
1.
190. Eur. Public Health Alliance, Eur. Health Card Launched, supra note 181.
191. Id.
192. See Press Release, Eur. Union, Eur. Health Insurance Card, supra note
187, at 1-2.
193. See U.K. Dep't of Health, The ECIC: Free or reduced cost treatment,
http://www.dh.gov.uk/ PolicyAndGuidance/ HealthAdviceForTravellers/ Getting
Treatment AroundThe World/ EEAAn Switzerland/ EEAAnd Switzerland
Article/ fs/en? CONTENTID =4114793 &chk=KCVYDZ (last visited Dec. 17,
2006).
194. See Press Release, Eur. Union, EU: European Health Insurance Card
Officially Launched (June 1, 2004), available at http://ec.europa.eu/ idabc/ en/
document/ 2589/ 330 [hereinafter EU Press Release, European Health Insurance
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E. European Charterof Patients' Rights

One of the most fundamental shifts from the view that health care is
strictly in the jurisdiction of individual member states to the view that a
legal right is tied to European Union treaty law has been the public
dialogue surrounding health care and health care reform in almost
every country. At this point in time, health care reform is viewed more
as a European-wide issue, exemplified by the European Charter of
Patients' Rights.' 96 The European Charter of Patients' Rights is a list
of fourteen patients' rights "currently at risk in all European countries
due to the financial crisis of national welfare systems."' '
Fifteen
national citizens' organizations compiled these rights.
These
organizations, along with other appropriate authorities, monitor their
respective Member States adherence to the charter.'9 8
The rights vary and include the right to preventative measures, the
right to information, and the right to privacy and confidentiality.'"
The most notable right for the issue of cross-border care is the right of
access, which states: "Every individual has the right of access to the
health services that his or her health needs require. The health
services must guarantee equal access to everyone, without
discriminating on the basis of financial resources,
place of residence,
2
kind of illness or time of access to services. 00
The issue of access is directly related to patient mobility. In March
2005, the European Parliament held a series of hearings entitled
"Patient Mobility in the European Union," inviting public policy
makers, politicians, patients, insurance companies, and other
stakeholders to offer both their views and their current research on the
status of patient mobility in the EU. °1 The fact that these hearings
Card]. See also Eur. Public Health Alliance, Eur. Health Card Launched, supra
note 181.
195. See EU Press Release, European Health Insurance Card, supra note 194.
196. See Eur. Charter of Patients' Rights, available at http:// www.
activecitizenship.net/ documenti/ European- Charter_ of_ Patients_ Rights- FinalDraft.pdf.
197. Active Citizenship Network, Eur. Charter of Patients' Rights,
http://activecitizenship.net/ projects/ project- europe_ chart.htm (last visited Nov.
11, 2006).
198. Eur. Charter of Patients' Rights, supra note 196 at pt. 4. The countries
involved with the Charter include Germany, Belgium, Portugal, Spain, Greece,
Italy, Ireland, Denmark, The Netherlands, Austria, and the United Kingdom.
199. Id. at pt. 2, secs. 1, 3, 6.
200. Id. at pt. 2, sec. 2.
201. See EUR. PARL. DEB., supra note 6.
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were even held illustrates the trends toward greater patient mobility
and cross-border health care.
There is, however, recognition that these developing trends cannot
go along unguided; simply opening borders does not provide the best
services for patients or providers. Rather, well-defined systems that
keep patients informed and organized are necessary. °2 Further,
programs or initiatives proposed to address these issues need to focus
on increased information sharing, with a goal of "health as a part of the
fundamental rights of EU citizens, with well defined patients' rights
and duties in Europe., 20 3 Forecasts include having an EU-level listing
of provider quality and accreditation, networks that would assess
medical technology (currently under development), a European health
an EU health card, and a defined European
information system with
24
"basket" of services. 0
In addition to being active regarding policy and program guidance,
patient mobility needs actual active cooperation between Member
States, especially those who border each other; these neighbors cannot
simply remove barriers to free movement.2 "' At the hearing, one
expert cited the example of the emergent border-region coordination
of cross-border care between the French and Belgian health systems.
This collaboration resulted in a legal basis for the creation of health
systems that "complete" each other rather than "compete with" each
other.2
A study presented at the hearing by the Picker Institute Europe, an
organization that specializes in measuring patient experience with and
2 0 7 provided some interesting
expectations of European Health systems,
results. According to the study, patients throughout Europe expressed
an interest in greater patient choice and access to cross-border care, as
well as favorable responses to the current EU-level reforms.0 8 The
study took place in Germany, Italy, Poland, Slovenia, Spain, Sweden,
Switzerland, and the UK and concluded that patients throughout
Europe want more information, involvement, choice, and control over
their own health care: 92% wanted free choice of primary care doctor,
85% wanted a free choice of specialist; and 86% wanted free choice of
202. See e.g., Remarks of Dorjan Marusic, EUR. PARL. DEB., supra note 6, at 12.
203. Remarks of Magda Rosenm6ller, EUR. PARL. DEB., supra note 6, at 4.
204. Id. at 4-5.
205. Remarks of Willy Palm, EUR. PARL. DEB., supra note 6, at 15.
206. Id.
207. See Picker Institute-Europe, What we do, http://www.pickereurope.org/
page.php?id=l (last visited Dec. 16, 2006).
208. See Remarks of Angela Coulter, EUR. PARL. DEB., supra note 6, at 17, 18.
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hospital. °9 When patients travel across borders for medical care, they
are becoming more discriminating and want information about both
the effectiveness and the safety of that foreign care.210
Overall,
respondents had a positive response to EU health cards as both an
electronic version of the Ell form and as an electronic patient
record.2 1
F. Examples of Cross-BorderCoordination
An example of the synergy of the four court rulings in a Member
State health care system is illustrated by Luxembourg, which due to its
small geographical size and lack of extensive internal health care
infrastructure experiences a higher utilization of cross-border care than
other, larger, Member States."'
According to Robert Kieffer,
President of Luxembourg's Union of Sickness and Maternity Insurance
Funds, in 1997, the year before the Kohll and Decker rulings, 2% of
the insured population of Luxembourg was approved for cross-border
care (8033 patients), with only 300 refusals. 213 After Kohll and Decker,
the insurance fund determined that there should be refunds for crossborder out-patient services according to Luxembourg tariffs.214 Prior
authorization was not required for cross-border out-patient services. 211
After Geraets-Smits, the state insurance fund required preauthorization for in-patient treatments abroad. 211 With these changes
making access to cross border care much simpler, the government
expected a reduction in E112 prior authorization requests, along with
an increase in transfers outside the country with refunds.217 There was,
suprisingly, a rise in E112 transfers between 1997 and 2003, increasing
from about 8,032 to over 12,000, a growth of 8% per year. 218 Still, those
seeking transfers outside the country with refunds at Luxembourg
tariff rates represented less than 0.5% of the services
. . provided
. 219 for outpatients, a small proportion of overall care reimbursements.
As the

209.
210.
211.
212.

Id. at 17.
See id.
See id. at 18.
Remarks of Robert Kieffer, EUR. PARL. DEB., supra note 6, at 24.

213.

Id.

214.

Id.

215.

Id.

216.

Id.

217.

Id.

218.

Remarks of Robert Kieffer, EUR. PARL. DEB., supra note 6, at 24.

219.

Id.
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Luxembourg case indicates, the ECJ rulings have led to an increase in
patient mobility; however, such a local reform resulting from the ECJ
rulings did not have a large impact on the country's system.2 0
Another example of cross-border coordination in health care
systems, recently analyzed by the European Commission, is in the
"Euregio Meuse-Rhine" region which involves parts of Belgium,
Germany, and the Netherlands. 221 The Euregio Meuse-Rhine has a
population of 3.7 million people, three languages (Dutch, German, and
French), four different cultures, and three legal systems.222 Beginning
as early as 1992, under an EU Community initiative, a cross-border
network was developed in which patients could seek treatment from
providers outside their own country. 223 The initial program called
INTERREG (starting in 1992) and INTERREG II (running from 1996
through 1999) integrated a series of multi-national hospitals and health
care insurers.2
Currently, the INTERREG III program (running
through 2006) provides for an expanded health care infrastructure.2
The current cross-border network involves five hospitals and ten
health insurance funds, and patients are recognized by their use of a
226
health care card similar to the EU health card.
Services provided
range from specialist medical treatment, prescription drugs, and
227
necessary hospital treatment.
The major accomplishments of the
program include: clinical cooperation of hospitals, cooperation of
sickness funds, the international health insurance card, cross-border
contracts between sickness funds and hospitals, cross-border contacts
of medical specialists, cross-border contacts of patient groups,
networks for the care of the elderly, and cooperation of institutes for
higher education.2
Due to these significant accomplishments, the
INTERREG programs could be used as a model for how to
proactively coordinate between health care systems in the European
Union while applying the decisions of Decker and Kohl.

220. Id. at 25.
221. EUR. COMM'N, e-Bus. Mkt. Watch, Case Study: Cross-Border Cooperation
for Healthcare Provision in Euregio Meuse-Rhine 1, http://www.ebusiness-

watch.org/ resources/ documents/ Case%20Studies%202004/ CSSR10_Health_2Euregio.pdf [hereinafter EUR. COMM'N, Case Study].

222.
223.
224.
225.
226.
227.
228.

Id.
Id. at 1-3.
Id. at 2.
Id.
See id. at 2, 4-5.
Id. at 4-5.
Id. at 9-10.
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Yet many questions remain concerning the overall utilization of
cross-border care in the European Union as a whole, and the financial
impact on Member State health care systems. Research has suggested
that there may be increases in expenditures in countries that have
embraced cross-border care, such as Belgium, Denmark, France,
Germany, Greece, Ireland, Luxembourg, the Netherlands, Portugal,
Spain, The United Kingdom, Austria, Finland, and Sweden. Home
state expenditures on patients receiving health care services in other
EU Member States per capita have risen from an average of E1.31 in
1989 to C1.99 in 1998." 9 Although more recent studies published in
2003 by the European Commission did not detect frequency or cost of
cross-border care during 2000-2001,23 o much of this data is considered
questionable, incomplete, or skewed due to waiver agreements
between countries and underreporting of actual service utilization.23'
Perhaps a more complete reporting of cross-border utilization would,
in the end, demonstrate a higher level of cross-border expenditures.2
For example, data suggests that Germany spent E4.70 per capita in
1992 and £5.40 in 2002; this amount is twice as high as reported in
previous studies. 3
Current research, to which we now turn, has
focused on case studies of regional areas as a model to understand
cross-border utilization in the European Union as a whole.
G. Learningfrom Experience: Europefor PatientsResearch Project
In 2006, the World Health Organization, on behalf of Europe for
Patients, a research and advocacy organization, published a book,
Patient Mobility in the European Union: Learning from Experience.
This work is an in-depth collection of nine case studies, each dealing
with a specific example of cross-border coordination in the European
Union. 3 4 Studies include cross-border care between Slovenia, Austria,
and Italy; access to health care for tourists in the Veneto region of

229. See WORLD HEALTH ORGANIZATION, European Observatory on Health
Systems and Policies, Policy Brief: Cross-BorderHealth Care in Europe, tab. I at
13 (2005) available at www.euro.who.int/ Document/ E87922.pdf (prepared by
Luigi Bertinato et al.).
230. Id. at 14.
231. Id.
232. Id. at 14-15.
233. Id.
234.

See EUROPE FOR PATIENTS, PATIENT MOBILITY IN THE EUROPEAN UNION:

LEARNING FROM EXPERIENCE (Magdalene Rosenmoller et al. eds., 2006), available
at www.iese.edu/ en/ files/ 6_22160.pdf [hereinafter EUROPE FOR PATIENTS,
PATIENT MOBILITY].
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Italy; and the sharing of health care resources between Malta and the
UK. 23 It appears that there are certain common themes that emerge
from these studies. These themes highlight both the complexity of the
cross-border health care question in addition to a great optimism that
increased cooperation and coordination between Member State health
care systems will increase positive health care outcomes for all. The
Europe for Patients Project, the organization behind the book, views
Kohll and Decker, as well as the subsequent Watts, Geraets-Smits, and

Vanbraekel decisions, as a starting point from which to develop more
opportunities for patients to access care across Member State
borders.236

According to these studies, most Europeans do not wish to use
foreign health systems:
[M]obility of patients across Europe's borders is a somewhat
marginal phenomenon as most patients prefer to be treated as
near to home as possible, close to their relatives, in a system they
are familiar with, and with providers who speak their language,
where theY3know what they can ask for and what they can expect
to receive.
Nevertheless, as the cases and reports discussed earlier demonstrate,
there is a noticeable amount of patient mobility that "can be an
important phenomenon in certain areas and contexts, such as tourist
areas and border regions ....

,238

Characteristics of those that seek cross-border medical care are also
varied, but the elderly make up a significant portion of the mobile
patient population, especially in popular tourist or retirement
destinations. 239 This has significant implications for future long term
care systems in these regions.2 4 Conversely, younger patients are more
likely to purposefully cross borders in order to obtain medical care
because the care is seen to be of "better quality" or "more
convenient. '' 241 Changing population demographics, as the elderly
population increases, and younger patients continue to cross borders to
seek care, may well impact the overall number of patients accessing
cross-border care.

235.
236.
237.
238.

See id. at vii-viii.
See e.g., id. at 19, 106-107, 158.
Id. at 179.
Id.

239. Id. at 179-180.
240. Id at 180.
241.

Id.
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Key conclusions and recommendations for the future of cross border
care are summarized by the principles proposed by Europe for
Patients.
These principles view cross border health care as an
opportunity to strengthen health care for all citizens of Europe, and all
Member States in the European Union. The principles rely upon
cooperation and information sharing between health care providers
and Member States to accomplish this goal. Cross border health care
is therefore seen as a way to improve Member health systems and
patient health outcomes. The recommendations are as follows:
Patient mobility should be managed...
Patient mobility requires trust. Purchasers must be able to rely
on standards being upheld by providers...
Patient mobility should clearly define specific arrangements
necessary to support the mobile patient, in relation to matters
such as transport, language and accompanying persons.
Patient mobility should ideally be integrated into larger forms of
cooperation involving providers of both countries...
Patient mobility should be based on prices set in a manner that is
transparent and which minimizes perverse incentives and
distortions of the market...
The competent authorities or purchasers should define explicit
eligibility criteria for patients who go abroad specifically to
obtain treatment.
The right to treatment abroad should be consistent with what is
included 2in42 the benefit package of the Member State that funds
the care.
VIII. CONCLUSIONS
The European Court of Justice and the decisions of Decker and
Kohll tried to balance two previously disparate legal rights: the
domestic right to heath care services within one's Member State of
residence and the European Union right of free movement and free
access to services across Member State borders. The Court found that
the restrictions on cross-border care to be in violation of EC Treaty
Articles 49 and 50; these portions of the TEC establish the right to
freedom of movement and freedom to receive services within the
European Community.143 Further jurisprudence in Geraets-Smits and
Vanbraekel applied the holding of Decker and Kohll to both
reimbursement and benefits-in-kind health care systems, allowing for

242. Id. at 185-186 (emphases omitted).
243.

See infra Part III.
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greater ease of patient mobility across the European Union.2" These
cases should be viewed within the context of a broader set of tensions
surrounding health care reform. The development of the European
Union, represents an ongoing renegotiation of the social contract, and
the future of the traditional social welfare state.
As already noted, a profound tension is inherent in cross-border
health care because the individual State's right to control its social
security/social protection system is at odds with the freedom of
movement which is at the core of the European Union. 245 In the case
of health care, this tension is exacerbated by the pressure for cost
containment in almost every European country as well as ongoing
discussions on health care reform.
Every major Western democracy is engaged in a public discussion of
the viability of the "social contract," the possible need to renegotiate
this "contract," and the implications of these deliberations for the
future of the social welfare state. 24' As this author has observed:
This "contract" between the State and society represents a
negotiated agreement between the government and citizens
over respective responsibilities and duties. The agreement
specifies what benefits government agrees to provide to
citizens in return for tax-based financing of these benefits; it
also recognizes the role of government in designing and
administering the
247 programs, which ultimately provide the
desired benefits.
The current economic situation in much of the Western world is
calling this social contract into question.
Reforms such as the introduction of a European Health Card 249 and
reform of Regulation 1408/71 (the key regulation governing crossborder care) 2 0 have removed many of the barriers to cross-border care
previously mentioned by the ECJ that were identified as problematic.
These reforms have also firmly cemented the right to cross-border care
developed in Decker and Kohll in European Union law and,
correspondingly, within the domestic law of Member State welfare
systems. Citizens of the European Union may now travel freely

244. See infra Part IV.
245. See infra Part V.
246. See generally, Rich, supra note 13 (discussing the "social contract," and its
place in western society with regards towards healthcare).
247. Id. at 397.
248. Id. at 420.
249. See supra Part VII.D.
250. See supra Part VII.C.
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between Member States to receive medical goods and services with
reimbursements provided under the tariffs of the patient's home
Member State."' Successes of cross-border care pilot programs, such
as the INTERREG program in the Meusue-Rhine region, have also
highlighted the successes of Member State health care system
252
cooperation.
The European Heath Card is perhaps the most visible change
brought about by the Decker and Kohll decisions. It is emblematic of
the very spirit of the rights established by Treaty Articles 49 and 50
and enforced by the Courts in these decisions. The Health Card is
currently in full use and is projected to eventually carry patient data
electronically.2 3 This card symbolizes the ease by which the European
patient can now move across Member States borders to receive most
foreign health care services without fear of lacking coverage. In fact,
cross-border health care was formerly a right granted to only workers
moving between Member States for economic reasons. Now it is a
right given to all citizens. This expansion of the right is representative
of the shift in defining the European Community as simply an
economic space to a cultural and social domain. Cross-border health
care is also an excellent example of how this shift is occurring through
the legal framework, both in terms of decisions of the European Court
of Justice and the overlay between the treaty-based structure of the
European Union and Member State legal rights. The structure of the
welfare state, with rights and benefits often guaranteed in Member
State law, is also being preserved and shaped by the European Court
of Justice, as has been seen in the Decker and Kohll cases.
In both Europe and the United States, the nature of the social
contract has shifted toward consolidation and retrenchment rather
254
than further expansion.
Consequently, the traditional "social
contract," with its strong social welfare components, has come under
increasing attack and its legitimacy has been called into question."'
Indeed, since 1980, policy-makers in many western countries have
taken steps to alter the mix and nature of benefits that comprise the
social contract; universalistic, service-based welfare states have
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undergone significant change."' An expansion of cross-border medical
care in the European Union, contrary to this treatment of the welfarestate, would represent a significant development in the opposite
direction.
Challenges still
exist for the system of cross-border care within the
Sr • 257
European Union.
Key difficulties include: expanding quality and
access to care in the newer Member States of the European Union,
dealing with issues of professional mobility, and increasing information
sharing and patient choice within the cross-border care legal structure.
Therefore, the issue of cross-border health care in the European
Union has in no way been resolved by either the ECJ decisions of
Decker and Kohll, the subsequent jurisprudence, or administrative
action by the European Union. However, Decker, Kohll, and similar
decisions do suggest that easing legal barriers to cross-border care
access may provide relief to Member States struggling with increasing
costs of health care and problems of resource allocation. Unlike
previous decisions to open borders on more static European issues
(e.g., higher education)258 health care systems are continually in flux as
population demographics shift, new technologies develop, and
community needs change and adapt. Future decisions on cross-border
care likely will reflect such a dynamic and provide insight into the
changing health marketplace, the interactions and evolution of the
European social contract, as well as the legal evolution of the
European Union itself.
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